Company: BSX
Filing Date: 2025-08-01
Form Type: 10-Q
Source: 0000885725-25-000041
Chunk: 75

Company: BOSTON SCIENTIFIC CORP
Filing Date: 2025-08-01
Form: 10-Q
Item: Part I, Item 1
Chunk 75
---
erventional Cardiology Therapies252 479 731 201 464 665 Watchman446 40 486 342 36 379 Cardiac Rhythm Management355 235 590 352 224 576 Electrophysiology587 252 840 271 157 428 Cardiology1,640 1,007 2,647 1,166 881 2,047 Peripheral Interventions402 296 698 308 281 590 Cardiovascular2,042 1,303 3,345 1,474 1,163 2,637 Total Net Sales$3,224 $1,837 $5,061 $2,466 $1,654 $4,120 Six Months Ended June 30,20252024BusinessesU.S.Int'lTotalU.S.Int'lTotalEndoscopy$876 $534 $1,410 $810 $508 $1,318 Urology967 342 1,310 719 319 1,038 Neuromodulation432 142 574 405 134 539 MedSurg2,275 1,018 3,293 1,933 961 2,895 Interventional Cardiology Therapies484 944 1,428 396 921 1,316 Watchman836 75 911 653 70 723 Cardiac Rhythm Management713 455 1,168 706 446 1,151 Electrophysiology1,099 472 1,570 429 300 729 Cardiology3,131 1,945 5,077 2,183 1,736 3,919 Peripheral Interventions778 576 1,354 608 555 1,163 Cardiovascular3,909 2,521 6,430 2,791 2,291 5,082 Total Net Sales$6,185 $3,539 $9,724 $4,724 $3,252 $7,977 Refer to Note J – Segment Reporting for information on our reportable segments.

35

Three Months Ended June 30,Six Months Ended June 30,Geographic Regions2025202420252024U.S.$3,224 $2,466 $